Related Experiment Video
Updated: Jul 2, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol.
Ferdaous Chahed1, Nadia Ben Fredj1, Haifa Ben Romdhane1
1Department of Clinical Pharmacology, University Hospital/Faculty of Medicine of Monastir, University of Monastir, 5000 Monastir, Tunisia.
Methimazole (MMI) is crucial for hyperthyroidism. Even with urticaria, MMI can be safely reintroduced using a gradual protocol with antihistamines, ensuring continued treatment success.
Area of Science:
- Endocrinology
- Pharmacology
- Dermatology
Background:
- Methimazole (MMI) is a preferred treatment for hyperthyroidism.
- Urticaria is a potential side effect of MMI.
- Safe re-administration protocols are essential for MMI-treated patients.
Purpose of the Study:
- To report a case series of methimazole-induced urticaria.
- To provide a stepwise protocol for the safe re-administration of MMI in patients with hyperthyroidism.
Main Methods:
- Retrospective case series of 11 patients with MMI-induced urticaria.
- Pharmacovigilance data from March 2013 to January 2022.
- Gradual MMI reintroduction protocol with antihistamines.
Main Results:
- Eleven patients (SR: 0.22) developed urticaria after MMI initiation (median 14.5 days, median dose 40mg).
- Urticaria resolved upon MMI withdrawal and antihistamine use.
- Successful MMI reintroduction in 10/11 patients using a stepwise dose escalation over 10 days with concurrent cetirizine.
Conclusions:
- MMI should not be withdrawn solely due to urticaria in hyperthyroid patients.
- A gradual reintroduction of MMI with antihistamine support is effective and safe.
- This approach allows for continued MMI therapy and successful hyperthyroidism management.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Desensitization and Tachyphylaxis

